These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9771099)

  • 1. [The role of dynamic contrast magnetic resonance tomography in the complex radiation diagnosis of focal hepatic lesions].
    Tiutin LA; Berezin SM; Rozengauz EV
    Vestn Rentgenol Radiol; 1998; (2):19-24. PubMed ID: 9771099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The tissue characterization of focal liver lesions with magnetic resonance imaging].
    Manfredi R; Maresca G; De Gaetano AM; De Franco A; Marano P
    Radiol Med; 1995 Sep; 90(3):250-61. PubMed ID: 7501830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential diagnosis of focal liver lesions: role of spin-echo and contrast-enhanced dynamic MR imaging.
    Yamashita Y; Hatanaka Y; Yamamoto H; Arakawa A; Matsukawa T; Miyazaki T; Takahashi M
    Radiology; 1994 Oct; 193(1):59-65. PubMed ID: 8090922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dynamic MR tomography of intrahepatic tumors].
    Hamm B; Felix R; Wolf KJ
    Rofo; 1989 Apr; 150(4):434-41. PubMed ID: 2539622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].
    Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L
    Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Magnetic resonance tomography of focal hepatic lesions using the para-magnetic contrast medium, gadolinium DTPA. First clinical results].
    Hamm B; Römer T; Felix R; Wolf KJ
    Rofo; 1986 Dec; 145(6):684-91. PubMed ID: 3025957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric liver: focal masses.
    Siegel MJ; Chung EM; Conran RM
    Magn Reson Imaging Clin N Am; 2008 Aug; 16(3):437-52, v. PubMed ID: 18585597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of benign and malignant focal liver lesions.
    Martin DR; Semelka RC
    Magn Reson Imaging Clin N Am; 2001 Nov; 9(4):785-802, vi-vii. PubMed ID: 11694438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
    Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
    AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing focal hepatic lesions by free-breathing intravoxel incoherent motion MRI at 3.0 T.
    Watanabe H; Kanematsu M; Goshima S; Kajita K; Kawada H; Noda Y; Tatahashi Y; Kawai N; Kondo H; Moriyama N
    Acta Radiol; 2014 Dec; 55(10):1166-73. PubMed ID: 24316660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].
    Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC
    Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis.
    Fowler KJ; Brown JJ; Narra VR
    Hepatology; 2011 Dec; 54(6):2227-37. PubMed ID: 21932400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence.
    Reimer P; Rummeny EJ; Shamsi K; Balzer T; Daldrup HE; Tombach B; Hesse T; Berns T; Peters PE
    Radiology; 1996 Apr; 199(1):177-83. PubMed ID: 8633143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
    Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
    Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging.
    Hamm B; Thoeni RF; Gould RG; Bernardino ME; Lüning M; Saini S; Mahfouz AE; Taupitz M; Wolf KJ
    Radiology; 1994 Feb; 190(2):417-23. PubMed ID: 8284392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal liver lesion detection and characterization with GD-EOB-DTPA.
    Purysko AS; Remer EM; Veniero JC
    Clin Radiol; 2011 Jul; 66(7):673-84. PubMed ID: 21524416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions.
    Ros PR; Freeny PC; Harms SE; Seltzer SE; Davis PL; Chan TW; Stillman AE; Muroff LR; Runge VM; Nissenbaum MA
    Radiology; 1995 Aug; 196(2):481-8. PubMed ID: 7617864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating focal eosinophilic liver disease from hepatic metastases using unenhanced and gadoxetic acid-enhanced MRI.
    Kim YK; Lee YH; Kim CS; Lee MW
    Abdom Imaging; 2011 Aug; 36(4):425-32. PubMed ID: 21748468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
    Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
    Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The integrated diagnosis of hepatic focal nodular hyperplasia: echography, color Doppler, computed tomography and magnetic resonance compared].
    De Gaetano A; De Franco A; Maresca G; Manfredi R; Barbaro B; Monteforte MG
    Radiol Med; 1996 Mar; 91(3):258-69. PubMed ID: 8628940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.